¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutral occlusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hyperfunctional occlusion
    ±â´ÉÇ×Áø¸Â¹°¸²
  • inverse occlusion
    ¹Ý´ë°¡¸²
  • impending occlusion
    Àý¹ÚÆó¼â
  • lateral occlusion
    °¡Âʸ¹°¸², Ãø¹æ±³ÇÕ
  • normal occlusion
    Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
  • occlusion
    1. ¸·Èû, Æó»ö, Æó¼â 2. ¸Â¹°¸², ±³ÇÕ 3. °¡¸²
  • occlusion amblyopia
    °¡¸²¿øÀξà½Ã
  • occlusion rim
    ±³ÇÕÅ×
  • posterior occlusion
    ¾Æ·¡Åεڸ¹°¸², ¿ø½É±³ÇÕ
  • punctal occlusion
    ´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
  • retrusive occlusion
    ¾Æ·¡Åεڸ¹°¸², ¿ø½É±³ÇÕ
  • stabilized occlusion
    ¾ÈÁ¤¸Â¹°¸², ¾ÈÁ¤±³ÇÕ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hyperfunctional occlusion
    (¢¡traumatic occlusion) ¿Ü»ó¹°¸²
  • impending occlusion
    Àý¹ÚÆó¼â
  • inverse occlusion
    ¹Ý´ë°¡¸²
  • lateral occlusion
    °¡Âʹ°¸², Ãø¹æ±³ÇÕ
  • occlusion
    ¸·Èû, Æó»ö, ¸Â¹°¸², °¡¸², Æó¼â
  • occlusion test
    ¸Â¹°¸²°Ë»ç, ±³ÇÕ°Ë»ç
  • occlusion therapy
    °¡¸²Ä¡·á
  • posterior occlusion
    (¢¡distocclusion) ¾Æ·¡Åεڹ°¸², ¿ø½É¸Â¹°¸², ¿ø½É±³ÇÕ
  • punctal occlusion
    ´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
  • retrusive occlusion
    (¢¡distocclusion) ¾Æ·¡Åεڹ°¸², ¿ø½É¸Â¹°¸², ¿ø½É±³ÇÕ
  • stabilized occlusion
    ¾ÈÁ¤¹°¸², ¾ÈÁ¤±³ÇÕ
  • traumatic occlusion
    ¿Ü»ó¹°¸²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progenia =opposite occlusion
    ÇϾÇÀüµ¹(Áõ)(ù»äÉîñÔÍñø), ¹Ý´ë±³ÇÕ(ÚãÓß Îáùê).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â (¡­øÍáð).
  • pulmonary venous occlusion
    ÆóÁ¤¸ÆÆó¼â(øËð¡ØæøÍáð)
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá).
  • renal arterial occlusion
    ½Åµ¿¸Æ Æó»ö(ãìÔÑØæøÍßá)
  • renal artery,occlusion of
    ¡­ÀÇ Æó¼â(øÍáð)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • neutral refractories
    Áß¼º³»È­¹°(~Ò±ûýÚª).
  • neutral salt
    Áß¼º¿°(ñéàõç¤).
  • neutral zone
    Áß¼º´ë(ñéàõÓá) »ö¸Í .
  • abnormal bite =occlusion
    ÀÌ»ó±³ÇÕ
  • abocclusion =abnormal occlusion
    °³±³(ËÒÎá).
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ôÃѵ¿¸Æ Æó¼âÁõÈıº.
  • anterior occlusion
    ÀüÃø±³ÇÕ(ÀüÃø±³ÇÕ).
  • arterial occlusion
    µ¿¸ÆÆó¼â.
  • arteriomesenteric duodenal occlusion
    Àå°£¸·µ¿¸Æ¼º ½ÊÀÌÁöÀå( ÊàØ¯ÔÑØæàõä¨ì£ò¦ )Æó¼â.
  • arteriomesenteric duodenal occlusion
    Àå°£¸·µ¿¸Æ¼º ½ÊÀÌÁöÀå( °£¸·µ¿¸Æ¼º½ÊÀÌÁö )Æó¼â.
  • balance bite =b. occlusion
    ÆòÇü¼º ±³ÇÕ(øÁû¬àõÎáùê).
  • balloon occlusion test
    dz¼±Æó¼â°Ë»ç
  • binocular occlusion
    µÎ´«°¡¸², ¾ç¾ÈÄ¡Æó
  • branch retinal artery occlusion
    ¸Á¸·µ¿¸ÆºÐÁöÆó¼â
  • branch retinal vein occlusion
    ¸Á¸·Á¤¸ÆºÐÁöÆó¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NAA N-acetyl aspartate; naphthaleneacetic acid; neutral amino acid; neutron activation analysis; neutrop...
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
NEP negative expiratory pressure; nephrology; neutral endopeptidase; no evidence of pathology
neut neuter, neutral; neutrophil
NF nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NR Neutral Red
NAA Neutral amino acid
ND Neutral density
NDF Neutral detergent fiber
NDF Neutral detergent fibre
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • curve of occlusion
    ±³ÇÕ ¸¸°î
    ÇöÁ¸ÇÏ´Â Ä¡¾ÆÀÇ Àý´Ü°ú ±³µÎÀÇ ´ëºÎºÐÀÌ µ¿½Ã¿¡ Á¢ÃËµÇ¸é ¸¸°î ¼±À¸·Î ¸éÀ» ÀÌ·ç´Âµ¥ À̸¦ ±³ÇÕ ¸¸°îÀ̶ó ÇÑ´Ù.
  • cuspid protected occlusion
    °ßÄ¡ º¸È£¼º ±³ÇÕ
    µ¿ÀǾî=canine-
  • dynamic individual occlusion
    °³º°Àû µ¿Àû ±³ÇÕ
  • edge to edge occlusion
    Àý´Ü ±³ÇÕ
    »óÇÏ¾Ç ÀüÄ¡ÀÇ Àý´Ü¸éÀÌ ¸Â¹°¸®´Â ±³ÇÕ °ü°è.
  • ideal occlusion
    ÀÌ»ó ±³ÇÕ
    »ó¾ÇÄ¡ ¹× ÇϾÇÄ¡ÀÇ »óÈ£ ÇÔÀÔ ±³ÇÕÀÌ ¿Ïº®ÇÑ »óÅÂ.
  • individual normal occlusion
    °³¼º Á¤»ó ±³ÇÕ
    Á¤»ó º¯À̳»¿¡ ÀÖ´Â °³ÀÎÂ÷¸¦ ÀÎÁ¤ÇÏ´Â Á¤»ó±³ÇÕ
  • interference of occlusion
    ±³ÇÕ °£¼·
    µ¿ÀǾî=su
  • lateral occlusion
    Ãø¹æ ±³ÇÕ
    ÇϾǰñÀÌ Ãø¹æ ¿îµ¿À» Çϰí Ä¡¾ÆÀÇ ±³ÇÕ ¸éÀÌ ¿ìÃø ȤÀº ÁÂÃø¿¡¼­ Ãø¹æÀ¸·Î Á¢ÃËÀ§¸¦ À¯ÁöÇÏ¿© 3Á¡ Á¢ÃËÀÇ ±ÕÇü À§¿¡ ÀÖ´Â »óÅÂ.
  • mesial molar occlusion
    ±Ù½É ±¸Ä¡ ±³ÇÕ
  • monoplane occlusion
    ´ÜÀÏ Æò¸é ±³ÇÕ
  • mutually protected occlusion
    »óÈ£ º¸È£¼º ±³ÇÕ, »óÈ£ º¸È£ ±³ÇÕ
  • normal occlusion
    Á¤»ó ±³ÇÕ
  • occlusion amblyopia
    °¡¸² ¾à½Ã
  • occlusion equilibration
    ±³ÇÕ Á¶Á¤
    1. ¸¸¼º º¯¿¬¼º Ä¡ÁÖ¿°
  • occlusion of deciduous teeth
    À¯Ä¡ ±³ÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neutral point The point at which a solution is neither acid nor alkaline (pH 7 at 22°C for aqueous solutions).
(05 Mar 2000)
neutral protease <enzyme> Protease that is optimally active at neutral pH:
See: proteases.
(18 Nov 1997)
neutral reaction PH of 7.00; H+ and OH- ion concentrations equal at 10-7 m at 22°C.
Compare: dissociation constant of water.
(05 Mar 2000)
neutral red <chemical> 3-amino-7-dimethylamino-2-methylphenazine hydrochloride. A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems.
Pharmacological action: dyes, indicators and reagents.
Chemical name: 2,8-Phenazinediamine, N8,N8,3-trimethyl-, monohydrochloride
(12 Dec 1998)
neutral spirits Spirits distilled from suitable raw materials, are 95% ethanol (v/v) that is, at least 190 proof when distilled. Used for blending with straight whiskey and for making gin, cordials, liqueurs, and vodka.
See: alcohol.
Proof spirit, dilute alcohol, specific gravity 0.920, containing 49.5% by weight (57.27% by volume) of C2H5OH at 15.56°C. Originally in Great Britain it was the weakest alcohol that would permit ignition of gunpowder moistened with it. British proof spirit has a specific gravity of 0.9198 and contains 49.2% C2H5OH by weight, or 57.1% by volume at the temperature of 10.56°C.
(05 Mar 2000)
neutral stain <technique> A compound of an acid stain and a basic stain, such as the eosinate of methylene blue, in which the anion and cation each contains a chromophore group.
Synonym: salt dye.
(05 Mar 2000)
neutral stimulus When paired with the unconditioned stimulus in simultaneous presentation to an organism, capable of eliciting a given response.
(05 Mar 2000)
neutral zone In dentistry, the potential space between the lips and cheeks on one side and the tongue on the other; natural or artificial teeth in this zone are subject to equal and opposite forces from the surrounding musculature.
(05 Mar 2000)
day neutral plant <botany> Plants that flower regardless of day length.
(09 Oct 1997)
lens neutral proteinase <enzyme> Degrades alpha 2-crystallin; requires ca and mg; cleaves phe-ser bond in bradykinin; similar enzyme found in human lung
Registry number: EC 3.4.24.5
Synonym: neutral proteinase 24.5
(26 Jun 1999)
abnormal occlusion An arrangement of the teeth which is not considered to be within the normal range of variation.
(05 Mar 2000)
acute vascular occlusion <cardiology, surgery> A serious condition that results from the sudden blockage of an artery, usually with a blood clot.
(27 Sep 1997)
afunctional occlusion A malocclusion which does not permit normal function of the dentition.
(05 Mar 2000)
anterior occlusion The occlusion of anterior teeth.
Synonym: mesial occlusion.
(05 Mar 2000)
aortic occlusion A blockage of the aorta somewhere along its path. This can result in irreversible damage to the organs which depend on aortic blood below the level of the blockage.
See: atherosclerosis.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á